Barclays
SMTI icon

Barclays’s Sanara MedTech SMTI Stock Holding History

Barclays’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$74.4K Sell
2,116
-157
-7% -$4.98K ﹤0.01% 4432
2026
Q2 		$53.6K Buy
2,273
+168
+8% +$3.47K ﹤0.01% 4302
2026
Q1 		$36.2K Sell
2,105
-4,201
-67% -$86.4K ﹤0.01% 4422
2025
Q4 		$147K Sell
6,306
-1,444
-19% -$37.3K ﹤0.01% 4463
2025
Q3 		$246K Sell
7,750
-1,103
-12% -$33.3K ﹤0.01% 4201
2025
Q2 		$251K Buy
8,853
+4,442
+101% +$133K ﹤0.01% 4138
2025
Q1 		$136K Sell
4,411
-2,012
-31% -$68.3K ﹤0.01% 4282
2024
Q4 		$213K Buy
6,423
+692
+12% +$23.5K ﹤0.01% 4278
2024
Q3 		$173K Buy
5,731
+4,376
+323% +$136K ﹤0.01% 4365
2024
Q2 		$38.2K Sell
1,355
-1,344
-50% -$42.2K ﹤0.01% 4305
2024
Q1 		$100K Sell
2,699
-2,637
-49% -$98.6K ﹤0.01% 4438
2023
Q4 		$219K Buy
5,336
+4,653
+681% +$149K ﹤0.01% 4376
2023
Q3 		$21.3K Sell
683
-74
-10% -$2.87K ﹤0.01% 4166
2023
Q2 		$30.4K Buy
+757
New +$31K ﹤0.01% 4033

Other funds holding SMTI

Transmarket Holdings
Transmarket Holdings Chicago, Illinois $179M AUM 32.06% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Hill Island Financial
Hill Island Financial Grand Rapids, Michigan $481M AUM 18.93% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Barclays's SMTI Position: Q3 2026 in Review

Barclays reduced its Sanara MedTech (SMTI) stake by 6.9% in Q3 2026, selling an estimated $4.98K and leaving 2,116 shares worth $74.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4432.

Barclays first reported a position in SMTI in Q2 2023 and has held it in 14 quarters since. The position peaked at $251K in Q2 2025. 36 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

  • Barclays held 2,116 shares of Sanara MedTech worth $74.4K as of Q3 2026.
  • Barclays sold 157 Sanara MedTech shares in Q3 2026, an estimated $4.98K.
  • Sanara MedTech made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4432 holding.
  • Barclays first reported a position in Sanara MedTech in Q2 2023 and has held it in 14 quarters since.
  • Barclays's Sanara MedTech position peaked at $251K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.